Clinical Trial: Vivity IOL: Emmetropia Compared to Monovision.

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof� IQ Vivity� Intraocular Lens Targeted for Emmetropia or Nanovision.

Brief Summary: Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Different options are available including: mono-vision and presbyopia correcting intraocular lenses (IOL). Presbyopia correcting IOLs include accommodative, multifocal, trifocal and extended depth of focus (EDOF) IOLs. The Vivity Extended Vision IOL is not a multifocal IOL but due to its design, it provides better intermediate and near VA compared to a monofocal IOL.